Semiquantitative analysis of immunohistochemical stains on human myelolipoma samples
| Sample ID . | CD34 . | CD73 . | CD90 . | CD146 . | CD271 . | CXCL12 . | NESTIN . | Anatomical origin . |
|---|---|---|---|---|---|---|---|---|
| A | + | / | +++ | +++ | / | ++ | +++ | Adrenal |
| B | - | + | - | ++ | + | + | ++ | Retroperitoneum |
| C | + | + | + | +++ | +++ | ++ | ++ | Pelvic |
| D | - | + | + | ++ | +++ | +++ | + | Adrenal |
| E | - | +++ | +++ | +++ | +++ | + | +++ | Adrenal |
| F | - | ++ | ++ | +++ | +++ | + | +++ | Adrenal |
| G | - | ++ | + | ++ | +++ | - | +++ | Adrenal (adenoma) |
| H | - | ++ | + | ++ | +++ | + | +++ | Adrenal |
| I | + | +++ | + | ++ | +++ | + | ++ | Pelvic |
| J | - | + | + | + | ++ | - | + | BM |
| K | + | + | ++ | ++ | +++ | + | +++ | Adrenal |
| Sample ID . | CD34 . | CD73 . | CD90 . | CD146 . | CD271 . | CXCL12 . | NESTIN . | Anatomical origin . |
|---|---|---|---|---|---|---|---|---|
| A | + | / | +++ | +++ | / | ++ | +++ | Adrenal |
| B | - | + | - | ++ | + | + | ++ | Retroperitoneum |
| C | + | + | + | +++ | +++ | ++ | ++ | Pelvic |
| D | - | + | + | ++ | +++ | +++ | + | Adrenal |
| E | - | +++ | +++ | +++ | +++ | + | +++ | Adrenal |
| F | - | ++ | ++ | +++ | +++ | + | +++ | Adrenal |
| G | - | ++ | + | ++ | +++ | - | +++ | Adrenal (adenoma) |
| H | - | ++ | + | ++ | +++ | + | +++ | Adrenal |
| I | + | +++ | + | ++ | +++ | + | ++ | Pelvic |
| J | - | + | + | + | ++ | - | + | BM |
| K | + | + | ++ | ++ | +++ | + | +++ | Adrenal |
Detailed semiquantitative histological characteristics of the different immunohistochemical stains on the myelolipoma samples and 2 controls (healthy BM [J] and adrenal adenoma [G]), quantification represent number of positive cells per samples (“-” corresponds to no positive cell; “+” to “+++” correspond to linearly increasing number of positive cells; and “/” corresponds to no data).